Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea

Journal of Dermatological Treatment

Volumn 14, Issue 4, 2003, Pages 212-215

  Lee, J H ^a   Lee, H S ^a   Eun, H C ^a   Cho, Kwang Hyun ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Ciclopirox; Dandruff; Ketoconazole

Indexed keywords

CICLOPIROXOLAMINE; KETOCONAZOLE;

ADULT; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DANDRUFF; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALASSEZIA FURFUR; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0344441776     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/jdt.14.4.212.215     Document Type: Article

References (19)

1. Pierard-Franchimont C, Hermanns JH, Degreef H, Pierard GE. From axioms to new insights into dandruff. Dermatology (2000) 200: 93-8.
2. Loden M, Wessman C, The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo. Int J Cosmet Sci (2000) 22: 285-9.
3. Hay RJ, Graham-Brown RAC. Dandruff and seborrheic dermatitis: causes and management. Clin Exp Dermatol (1997) 22: 3-6.
4. Aron-Brunetiere R, Dompmartin D, Drouhet E, Treatment of pityriasis capitis (dandruff) with econazole nitrate. Acta Derm Venereol (1977) 57: 77-80.
5. Danby FW. Stuart WM, Margesson LJ, Rosenthal D. A randomized. double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol (1993) 29: 1008-12.
6. Peter RU. Richarz-Barthauer U, Successful treatment and prophylaxis of scalp seborrheic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre double-blind, placebo-controlled trial. Br J Dermatol (1995) 132: 441-5.
7. Dupuy P, Maurette C, Amoric JC et al. Randomized placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrheic dermatitis. Br J Dermatol (2001) 1033-7.
8. Gupta AK, Ciclopirox: an overview. Int J Dermatol (2001) 40: 305-10.
9. Baroni A, De Rosa R, De Rosa A et al. New strategies in dandruff treatment: growth control of Malassezia ovalis. Dermatology (2000) 201: 332-6.
10. Bulmer AC, Glenn S, The antifungal action of dandruff shampoos. Mycologica (1999) 147: 63-5.
11. Shuster S. The aetiology of dandruff and mode of action of therapeutic agents. Br J Dermatol (1984) 111: 135-42.
12. Gupta AK, Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. J Am Acad Dermatol (2000) 43: s81-s95.
13. Abrams BB, Hanel H. Hoehler T, Ciclopirox olamine: a hydroxypyridone antifungal agent. Clin Dermatol (1991) 9: 471-7.
14. Yu B, Zhou G, Wang B et al. A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis. Chim Med Sci J (1991) 6: 166-8.
15. Sehgal VN, Ciclopirox: a new topical pyridonium antimycotic agent. A double-blind study in superficial dermatomycoses. Br J Dermatol (1976) 95: 83-8.
16. Lassus A, Nolting KS, Savopoulos C. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydroxycortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clin Ther (1988) 10: 594-9.
17. Oliveri S, Cammarata E, Cappello G et al. Ciclopirox olamine: clinical and microbiological considerations. Preliminary data. Chemioterapia (1986) 5: 23-5.
18. Jue SG, Dawson GW, Brogden RN, Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs (1985) 19: 330-41.
19. Rosen T, Schell BJ, Orengo I, Anti-inflammatory activity of antifungal preparations. Int J Dermatol (1997) 36: 788-92.